Mutations in several genes, including Parkin, PTEN-induced kinase 1 (Pink1) and DJ-1, are associated with rare inherited forms of Parkinson's disease (PD). Despite recent attention on the function of these genes, the interplay between DJ-1, Pink1 and Parkin in PD pathogenesis remains unclear. In particular, whether these genes regulate mitochondrial control pathways in neurons is highly controversial. Here we report that Pink1-dependent Parkin translocation does occur in mouse cortical neurons in response to a variety of mitochondrial damaging agents. This translocation only occurs in the absence of antioxidants in the neuronal culturing medium, implicating a key role of reactive oxygen species (ROS) in this response. Consistent with these observations, ROS blockers also prevent Parkin recruitment in mouse embryonic fibroblasts. Loss of DJ-1, a gene linked to ROS management, results in increased stress-induced Parkin recruitment and increased mitophagy. Expression of wild-type DJ-1, but not a cysteine-106 mutant associated with defective ROS response, rescues this accelerated Parkin recruitment. Interestingly, DJ-1 levels increase at mitochondria following oxidative damage in both fibroblasts and neurons, and this process also depends on Parkin and possibly Pink1. These results not only highlight the presence of a Parkin/Pink1-mediated pathway of mitochondrial quality control (MQC) in neurons, they also delineate a complex reciprocal relationship between DJ-1 and the Pink1/Parkin pathway of MQC.
INTRODUCTION
Parkinson's disease (PD), a neurodegenerative movement disorder, is characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (1) . Growing evidence implicates mitochondrial quality control (MQC) pathways. Mitochondrial defects have been noted in PD patients (2, 3) . Moreover, exposure to drugs that inhibit mitochondrial complex I mimics certain aspects of PD (4 -6) . Interestingly, a number of recessive, early-onset PD genes are implicated in the maintenance of mitochondrial homeostasis. PTEN-induced kinase 1 (Pink1) is a serine/threonine kinase containing an N-terminal mitochondrial-targeting motif (7) . Pink1 localizes to mitochondria (7 -9) , and its loss leads to increased oxidative stress and sensitization to death (10, 11) . Parkin, another PD gene, possesses E3 ligase activity (12) . At least in select tumor lines in response to carbonyl cyanide m-chlorophenyl hydrazone (CCCP)-induced mitochondrial depolarization, Parkin translocates to mitochondria and participates in clearance of dysfunctional mitochondria (13) in a Pink1-dependent manner (14) (15) (16) (17) . Whether this is true in primary neurons is unclear. Critically, recent reports have indicated that neither CCCP (18) , nor mitochondrial damage caused by mitochondrial transcription factor A (TFAM) loss (19) induces Parkin † The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. * To whom correspondence should be addressed at: David S. Park, PhD, Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada K1H 8M5. Tel: +1 6135625800, ext. 8816; Fax: +1 6135625434; Email: dpark@uottawa.ca translocation in neurons, seriously undermining the relevance of the Pink1/Parkin MQC pathway in neurodegeneration.
DJ-1, a third PD recessive PD gene, is critical in oxidative stress response (20) (21) (22) and modulates various survival pathways (23) (24) (25) . We and others have shown that DJ-1 loss results in hypersensitization of neurons to oxidative damage (22, 26) . How this sensitivity occurs is unclear. Recently, we demonstrated that DJ-1 deficiency leads to a fragmented mitochondrial phenotype, which can be rescued, by Parkin or Pink1 (27) . However, while DJ-1 consistently appears to modulate oxidative stress responses (21, 22) , Parkin translocation is reported to not involve reactive oxygen species (ROS) (13) . These inconsistencies led us to more carefully examine whether DJ-1 participates in the Pink1/Parkin MQC pathway. In summary, two central questions have emerged: (a) does DJ-1 interact with the Pink1/Parkinmediated pathway of MQC and (b) are these pathways relevant in primary neurons.
Presently, we show that DJ-1 integrates into the classical Pink1/Parkin pathway by both modulating Parkin translocation/mitophagy and responding to Pink1/Parkin by increasing its level at mitochondria during oxidative stress. Moreover, we provide critical evidence that Parkin translocation to mitochondria does occur in primary neurons in a ROS-dependent manner. Taken together, we provide a model by which DJ-1 acts in a complementary fashion to regulate a ROS-dependent Pink1/Parkin-mediated MQC pathway in neurons.
RESULTS

Loss of DJ-1 results in earlier Parkin recruitment to mitochondria in mouse embryonic fibroblasts
Specific Parkin recruitment to mitochondria has been documented in response to mitochondrial depolarization following CCCP (13) or valinomycin (28) treatment and hydrogen peroxide treatment (28) in a number of cell lines. Previous reports from our laboratory (27) and others (20) have also established a role for DJ-1 in the regulation of ROS and maintenance of mitochondrial dynamics. Accordingly, we first examined whether the loss of DJ-1 affects Parkin recruitment to the mitochondria. DJ-1-deficient mouse embryonic with the mitochondrial uncoupler CCCP for various durations and analyzed for formation of Parkin puncta as previously described (13) . Within 1 h of 10 mM CCCP treatment, we observed noticeable mitochondrial translocation of wild-type (WT) Parkin (Fig. 1A and B) but not the PD-related mutant C431F (Fig. 1C) in WT MEFs. In the absence of DJ-1, however, the amount of cells displaying Parkin translocation was significantly higher after 1 h of CCCP treatment (Fig. 1A, and B ). These data demonstrate that DJ-1-deficient mitochondria are hypersensitized to depolarization-induced stress and recruit Parkin earlier.
DJ-1 is known to regulate ROS (20, 21) . In addition, absence of DJ-1 leads to increased ROS under a number of conditions (27, 29) . Accordingly, a plausible explanation for the observed earlier recruitment of Parkin to mitochondria in the absence of DJ-1 is increased oxidative stress. However, previous reports in HeLa cells indicated that ROS was not involved in mediating Parkin translocation (13) . We questioned whether there was something unique about HeLa cells that made them unresponsive to ROS. To address this discrepancy, we more carefully examined the requirement of ROS in our present studies in MEFs. WT MEFs were pre-treated with the antioxidants N-acetyl cysteine (NAC; 2 mM) or TIRON (100 mM) for 3 h before the addition of CCCP. As evident from Figure 2A , Parkin translocation was noticeably inhibited by both NAC and TIRON even after 2 h of CCCP treatment. Consistent with previous reports, we observed that NAC treatment, however, failed to prevent Parkin translocation in HeLa cells (Fig. 2B and Supplementary Material, Fig. S1 ). To further support the importance of ROS in Parkin translocation, we tested whether WT DJ-1 or a cysteine-106 to alanine mutant (C106A) mutant of DJ-1, known to be deficient in response to oxidative stress, could alter Parkin translocation kinetics. Importantly, earlier translocation of Parkin observed in DJ-1-deficient MEFs was restored to WT levels by exogenously expressing WT DJ-1, but not the mutant C106A DJ-1 (Fig. 2D) . Consistent with previous reports in other cell types, Parkin translocation in MEFs was observed to be Pink1-dependent since Parkin translocation did not occur in a Pink1-deficient background (Fig. 2E) . Finally, in line with previously published results (28) , Parkin translocation was also induced by 5 h of 100 mM hydrogen peroxide (H 2 O 2 ) treatment in WT MEFs (Supplementary Material, Fig. S2 ). Taken together, our results indicate that the ROS environment (known to be regulated by DJ-1) is an essential regulator of Pink1-mediated Parkin translocation, at least in non-transformed cell types.
It has been reported previously (13) that once recruited to mitochondria, Parkin selectively mediates the clearance of these damaged mitochondria by activating mitophagy. To test whether mitochondrial clearance was also heightened in DJ-1 knockout (KO) MEFs, we analyzed the total mitochondria per cell, in both Parkin-overexpressing WT and DJ-1 KO MEFs after treatment with 10 mM CCCP for 6 h (Fig. 3) . Compared with vehicle-treated cells (0 h), a noticeable decrease in the number of mitochondria was observed after 6 h of CCCP treatment in both WT and DJ-1 KO MEFs. Interestingly, mitochondrial-staining intensity after CCCP treatment was significantly lower in DJ-1-deficient MEFs compared with WT MEFs (Fig. 3B) . These results suggest that earlier recruitment of Parkin in DJ-1-deficient cells is also accompanied by faster clearance of the damaged mitochondria.
Stress-induced increase in mitochondrial DJ-1 is dependent upon Parkin in MEFs
The results above indicate that DJ-1 loss leads to earlier Parkin translocation, suggesting a critical role for DJ-1-mediated ROS regulation in Parkin function. We next determined whether the converse may be true, i.e. whether any function of DJ-1 may be impacted by Parkin/Pink1. Previous evidence indicated that the level of mitochondrial DJ-1 increases in response to H 2 O 2 -induced oxidative stress in SK-N-BE(2)C human neuroblastoma cells (30) and paraquat-induced stress in M17 neuroblastoma cells (20) . Accordingly, we explored how this increase may be impacted by Parkin/Pink1 deficiency. To determine levels of DJ-1 at mitochondria upon induction of oxidative stress in our present system, WT MEFs were treated with 100 mM H 2 O 2 for up to 6 h and the cytoplasmic and mitochondrial-enriched fractions were separated by sub-cellular fractionation for analysis by immunoblot (Fig. 4) . Equal amounts (10 mg) of mitochondrially enriched fractions from each time point were loaded and a whole-cell lysate from DJ-1 KO MEFs was included as a negative control. Following 1 h of H 2 O 2 treatment, a significant increase (Fig. 4A ) in the level of DJ-1 was observed at mitochondria, and this augmented level was maintained at both 3 and 6 h posttreatment. Immunoblotting against the 39 kDa subunit of Complex I (NDUFA9) or mitochondrial heat shock protein 70 (mtHSP70) was performed as a loading control. Additionally, we noted no substantial increase in whole-cell levels of DJ-1 with H 2 O 2 treatment, indicating that the observed increased level of DJ-1 in the mitochondrial-enriched fraction is not simply due to increased global levels of DJ-1 in the cell (Supplementary Material, Fig. S3A ). We also noticed endoplasmic reticulum (ER) contamination, as observed by the ER marker calnexin in our mitochondrial-enriched fractions (Supplementary Material, Fig. S4A ). Accordingly, we could not rule out DJ-1 at the ER (however, see data for neurons below). We next determined whether oxidative stressmediated increase in mitochondrial DJ-1 might in turn be increase of mitochondrial DJ-1 in WT MEFs is absent with Parkin deficiency (Fig. 4A ). This lack of increase in mitochondrial DJ-1 indicates that Parkin is required for stress-induced response of DJ-1 to mitochondria increase. While Pink1 deficiency resulted in higher basal DJ-1 levels at the mitochondria, mitochondrial DJ-1 levels did not further increase with oxidative stress (Fig. 4) stimuli such as CCCP (18) or in the absence of TFAM (19) does not appear to occur in neurons. This is a critical issue when it comes to determining whether or not MQC may be involved in degeneration observed in PD. Under routine culture conditions in media containing B27 supplement used for cortical neurons, we also failed to observe any Parkin translocation following induction of mitochondrial damage. To analyze for this translocation in neurons, we infected E15.5 mouse cortical neurons with an Adeno-associated virus (AAV) encoding the human Parkin gene fused to emerald-GFP. Parkin expression, observable as diffuse GFP florescence throughout the neuronal cell body, could be seen after 6-7 days of infection. With extended time courses and dosing ranges of CCCP, 1-methyl-4-phenylpyridinium (MPP + ) or rotenone, we could not observe any Parkin translocation. Interestingly, however, we could detect mitochondrial fragmentation within 1 h of CCCP treatment or 9 h of MPP + treatment, indicating that the agents utilized were having an effect on mitochondria (Fig. 5) . Our previous data in MEFs, however, suggested that ROS is a critical mediator of Parkin translocation. The supplement B27 contains numerous antioxidants including reduced glutathione, vitamin E (dl-a-tocopherol), catalase and superoxide dismutase. Accordingly, we reasoned that perhaps translocation was not observed in neurons because of the antioxidant-enriched media. To test this, we compared cells cultured in the presence or absence of B27 supplement. Initial experiments using poly-D-lysine (PDL)-only coated coverslips resulted in detachment of majority of neurons during drug treatments and the subsequent staining procedure. For this reason, cortical neurons derived from WT CD-1 E15.5 mice embryos were plated on acid-treated coverslips, coated with PDL and laminin. Indeed, a comparison of Parkin localization in cortical neurons cultured in the presence or absence of B27 revealed appearance of intense punctate Parkin staining in the cell bodies of the neurons after 5 mM CCCP, 0.05 mM rotenone or 20 mM MPP + treatment (Fig. 6A) . Quantification of the number of neurons displaying punctate Parkin staining revealed a statistically significant increase in cells displaying Parkin puncta after oxidative stress ( Fig. 6B and C). We should note that the time course of CCCP and MPP + -induced Parkin translocation differs likely due to delayed mitochondrial damage as observed by fragmentation.
These observations not only demonstrate a change in Parkin translocation following oxidative damage in neurons, but also suggest that Parkin translocation is ROS-dependent.
Parkin translocation in cortical neurons and mitophagy
To analyze the localization of the Parkin puncta, we performed co-labeling immunofluorescence studies. Cortical neurons from E15.5 mouse embryos were infected with GFP-Parkin-encoding AAV and treated with 0.05 mM rotenone after 7 days of culture. We first tested whether these puncta co-localized with mitochondrial markers. All mitochondrial markers used, such as TOM20, Complex IV subunit 1, Complex V and an artificial mitochondrial matrix cargo Oct4-dsRed (data not shown), all exhibited partial co-localization with the Parkin puncta in cells treated with different than that observed in CCCP-treated neurons (compare Fig. 6A rotenone and MPP + -treated with CCCP-treated), those previously shown in MEFs (Fig. 1 ) and those reported in other cell types where there was more prominent overlap with mitochondrial staining.
Parkin is an E3-ubiquitin ligase and translocated Parkin has been shown to enhance ubiquitination at the clustering mitochondria in HeLa cells (16, 31) . We were curious as to whether the punctate Parkin observed in the neurons overlap in any way with ubiquitination. To test this, we co-stained rotenone-treated, Parkin overexpressing cortical neurons with an antibody recognizing ubiquitin (Fig. 7B) . A diffuse cytoplasmic staining of ubiquitin was observed in control cells. Interestingly, rotenone-treated cells exhibited notable overlap of ubiquitin staining with Parkin puncta consistent with enhanced ubiquitination reported previously (16, 31, 32) .
We also performed co-staining for endogenous LC-3 as a marker for autophagy. LC-3 attaches to early autophagic vesicles during autophagosome biogenesis and is widely used as a marker for autophagy induction (33) . Since previous reports (13) had demonstrated that in cell lines, Parkin translocation precedes mitochondrial clearance by autophagic vesicles by a process termed mitophagy, we investigated whether the Parkin puncta observed in cortical neurons could also be mitophagic in nature. Some overlap of Parkin puncta with the endogenous LC-3 staining was observed (Fig. 7C ). These observations indicate that there are indeed MQC processes occurring in primary neurons in an ROS-dependent fashion. However, this process appears to be qualitatively quite different from those observed in other cell types.
Parkin translocation in DJ-1-or PINK1-deficient neurons
We next determined whether the observed aggregation of Parkin in primary neurons was dependent upon Pink1 and DJ-1, as we have explored in MEFs. Cortical neurons derived from WT and Pink1-deficient E15.5 mice embryos were plated on acid-treated coverslips, coated with PDL and laminin. The neurons were infected with GFP -Parkin expressing AAV at the time of plating. Seven days post-plating, the media were changed to fresh growth media lacking B27, as mentioned before, followed by drug treatments. Within 2 h of 5 mM CCCP treatment, significant increase in cells displaying mitochondrially translocated Parkin could be observed (Fig. 8A) in WT cortical neurons. However, consistent with observations in Pink1 KO MEFs, no punctate Parkin staining was observed in Pink1-deficient neurons, even after 4 h of CCCP treatment. These results indicate the presence of an active Pink1/Parkin pathway in primary neurons in response to mitochondrial damage.
Furthermore, similar experiments were performed in primary cortical neuronal cultures from DJ-1-deficient mice. We observed that, in comparison to WT neurons, Parkin translocation was accelerated in the absence of DJ-1, following treatment with either 5 mM CCCP or 20 mM MPP + (Fig. 8B) . We also investigated whether the observed Parkin translocation phenotype in DJ-1-deficient neurons could be rescued by overexpressing WT DJ-1 (Fig. 8D) . Similar to MEFs, exogenously expressed WT DJ-1 but not C106A mutant could restore CCCP-induced Parkin translocation levels to those observed in WT neurons. These results provide further evidence of sensitization of DJ-1-deficient cells to mitochondrial damage and therefore suggest an earlier activation of the Pink1/Parkin pathway of mitochondrial damage control.
An important consequence of the activation of the Pink1/ Parkin pathway of mitochondrial clearance would be increased survival of cells that can more efficiently clear damaged mitochondria. To test whether Parkin overexpression and therefore increased MQC does confer a survival advantage to cells under oxidative stress conditions, we analyzed the survival status of cells overexpressing WT Parkin or the E3-ubiquitin ligase mutant C431F after 6 h of 0.05 mM rotenone or 48 h of 20 mM MPP + treatment (Fig. 8E) . Under both oxidative stress conditions, overexpression of WT Parkin offered a modest but significant increase in survival when compared with the C431F mutant. These observations provide further support for a functional Pink1/Parkin pathway in neurons. However, care must be taken in interpreting these survival results since the E3 ligase activity of Parkin may have other functions than regulating MQC.
Increase of mitochondrial DJ-1 in primary neurons with oxidative stress
The above results further implicate DJ-1 in MQC. We next explored whether increased mitochondrial DJ-1 also occurs in primary neurons and whether this was dependent upon Pink1 similar to that observed in MEFs. WT primary cortical neurons from E14.5 -15.5 were treated with 30 mM H 2 O 2 , 10 mM MPP + or 10 mM CCCP in absence of antioxidants on DIV 6 (Fig. 9) . Equal amounts (10 mg) of mitochondrially enriched fractions from each time point were loaded. At 1 h of H 2 O 2 treatment, a significant increase (Fig. 9A) in the level of DJ-1 at mitochondria was observed in cortical neurons. Sustained maintenance of these DJ-1 levels was also observed until 6 h of H 2 O 2 treatment. Similarly, by 3 h treatment with MPP + and 1 h treatment with CCCP, the level of mitochondrial DJ-1 was significantly increased (Fig. 9) . Similar to MEFs, we also noted no significant increase in whole-cell levels of DJ-1 with any treatment (Supplementary Material, Fig. S3B and C) . These results demonstrate increased levels of DJ-1 at mitochondria in primary cortical neurons in response to oxidative stress by various agents, most notably the PD-linked drug MPP + . To further confirm DJ-1 increase at the mitochondria and to rule out changes in DJ-1 levels due to contaminating ER (Supplementary Material, Fig. S4B ), we investigated changes in mitochondrial DJ-1 using immunofluorescence. WT cortical neurons obtained as previously mentioned were plated onto PDL-coated coverslips at a density of 100 000 cells per well of a 24-well dish. These neurons were treated, in absence of antioxidant supplementation, on DIV 6 with either 10 mM MPP + (6 h) or 10 mM CCCP (1 h). Neurons were stained for endogenous DJ-1 and a mitochondrial marker, mtHSP70. Control neurons exhibited mostly ubiquitous staining for DJ-1 while neurons treated with either MPP + or CCCP showed punctate DJ-1 staining that partially co-localizes with mitochondrial staining (Supplementary Material, Fig. S5 , white arrows). Quantification is representative of at least three independent experiments. n.s., not significant; * P , 0.05 and * * P , 0.001; t-test for related samples.
Owing to the large amount of cytoplasmic staining of DJ-1 as well as the large amount of mitochondria in the cell body, we focused on the neuronal processes for demonstrating DJ-1 punctate staining. These observations further support our previous findings using cellular fractionation that DJ-1 levels increase at mitochondria following oxidative stress in neurons. Importantly, in line with our observations in MEFs, no further increase in DJ-1 levels was observed in Pink1-deficient neurons after MPP + -induced stress (Fig. 10) . It is also important to note that again, basal DJ-1 seems to be higher at mitochondria with Pink1-deficiency (Fig. 10) , perhaps due to an increase in basal ROS known to occur with Pink1 deficiency (10) . Unlike in the MEFs, Pink1 deficiency increased basal levels of total DJ-1 in cortical neurons, perhaps accounting for the increased basal level of mitochondrial DJ-1 in this cell type ( Supplementary  Material, Fig. S3E ). Unfortunately, we could not obtain breeding from Parkin KO mice pairings required to test for Parkin involvement in mitochondrial DJ-1 levels in neurons. 
DISCUSSION
Numerous recent studies have reported the individual roles of DJ-1, Parkin and Pink1 in the regulation of mitochondrial function (13, 14, 29, 34) . However, how these proteins relate to each other under situations of oxidative stress and the relevance of this interplay in PD pathogenesis is not completely clear.
Our present work addresses two critical questions in relation to the molecular and functional interactions between these PD-associated genes, namely: does DJ-1 have any significance in the Pink1/Parkin MQC pathway; and secondly, is oxidative stress central to Parkin translocation? Although the role of Pink1 and Parkin in MQC has been well described, the role of DJ-1 at mitochondria remains less certain. Previous work from our laboratory (27) and others (29) has shown that loss of DJ-1 leads to basally increased levels of ROS and deregulated mitochondrial dynamics suggesting a loss of MQC. Furthermore, loss of mitochondrial integrity would cause cells to be sensitized to additional oxidative stress, which we have previously observed with DJ-1 deficiency both in vitro and in vivo (22) . However, how and whether DJ-1 associates to MQC pathways is unknown.
Presently, we provide critical evidence that DJ-1 does indeed impact the Parkin translocation-mediated pathway of MQC both in MEFs and neurons in response to CCCP. DJ-1 deficiency enhances Parkin translocation. Interestingly, this result is dissimilar from a previous report in which transient knockdown of DJ-1 in HeLa cells did not have any significant effect on Parkin translocation (14) . Although the reason for this is unclear, it may involve the peculiarities of HeLa cells in regard to what we have observed with their response to ROS. Interestingly, HeLa cells usually lack endogenous levels of Parkin and may have activation of compensatory mechanisms to deal with damaged mitochondria.
The potential reason for DJ-1 regulation of Parkin translocation in response to abrupt depolarization is unclear. While there are a number of functions attributed to DJ-1 including transcription regulation and chaperone abilities (35) (36) (37) (38) , the most prominent is the ability of DJ-1 to manage ROS. Mitochondria deficient in DJ-1 are reported to produce more ROS (27) . This increase occurs through numerous potential mechanisms including regulation of Nrf2 (39), a master antioxidant regulator, and the pro-survival Akt pathway (25) . It is possible that increased ROS leads to increased mitochondrial damage, which increases the need for Parkin-initiated MQC. This would also suggest that ROS plays a central role in signaling and/or mediating mitochondrial damage, resulting in specific Parkin activation. Indeed, our present work would support this hypothesis.
While the evidence above suggests that DJ-1 influences Parkin recruitment, the reciprocal also appears to be true, i.e. stress-induced increase in mitochondrial DJ-1 is mediated by Parkin. Whether this is dependent upon Parkin recruited at mitochondria or Parkin in the cytoplasm is unknown. Additionally, it is important to note that in this scenario, the role of Pink1, while clear for Parkin translocation, is less clear for DJ-1. While no oxidative stress-induced increase in DJ-1 at mitochondria was detected with Pink1 loss, increased total DJ-1 expression and increased level of mitochondrial DJ-1 were observed under basal conditions. This basal increase in DJ-1 is reasonable given that Pink1 loss is also reported to increase the ROS environment (10) and perhaps accounts for the increased levels of DJ-1 at the mitochondria. Stress-mediated increase in mitochondrial DJ-1, however, likely involves Pink1 since no further increase in DJ-1 levels was observed following oxidative stress in Pink1-deficient cells. Alternatively, it is also plausible that the levels of DJ-1 at the mitochondria are saturated in these cells and may not increase after induction of stress. Finally, it is important to note that we have not ascertained the source of the increased mitochondrial DJ-1. However, our data suggest that it is not due to a global increase in DJ-1.
What is the potential role of mitochondrial DJ-1? Previous work has demonstrated that this mitochondrial translocation promotes survival of cells in response to oxidative stress (30) . How survival is affected is unknown. Our unpublished data suggest that DJ-1 loss reduces PGC1-a levels, a key mediator of mitochondria biogenesis, which was shown to be regulated by DJ-1 activity (40) . In addition, DJ-1 deficiency decreases fusion rates, which predisposes cells to death (27) . Whether these mechanisms are facilitated by only mitochondrial DJ-1 is unclear. Taken together, these data fit a model by which a Parkin-mediated signal induced by oxidative damage initiates a survival response of increased DJ-1 at mitochondria, perhaps to limit oxidative damage-although this has yet to be directly tested. Presumably, as our data would suggest, cells lacking DJ-1 would not be able to initiate this survival response at mitochondria, and the resulting increased mitochondrial damage would promote an even greater translocation of Parkin to further activate MQC (see Fig. 11 for summary).
While the above evidence presents a model of reciprocal relationship between DJ-1 and Parkin, its physiological relevance is unclear. There is controversy at least on two levels. First, most work on Parkin translocation has focused on CCCP. How biologically relevant this artificial and robust method of rampant and complete depolarization of mitochondria is to the neurodegenerative process remains unknown. Second, whether this translocation occurs in any robust fashion in neurons is also unclear. Previous reports indicate that it does not, at least with CCCP (18) and TFAM loss (19) . In support of this, we initially had difficulty detecting any Parkin translocation with CCCP or any other mitochondrial-damaging agents in cultured neurons under routine culture conditions. However, we observed that treatment with these agents did induce depolarization and massive mitochondrial fragmentation (Fig. 5) . These results indicated that the lack of Parkin translocation was not due to lack of biological effect of these agents and that Parkin translocation can be separated from fission events. The latter is particularly interesting since recent reports suggest an active role for Parkin in maintaining mitochondrial morphology (41, 42) . Importantly, it has been shown that Parkin can ubiquitinate Mitofusin 1 and 2 (42), key molecules regulating mitochondrial fusion, leading to the degradation of these molecules and increasing mitochondrial fission. Results presented here, however, suggest that recruitment of Parkin to mitochondria occurs after induction of mitochondrial fission. It is therefore unlikely that fission events are directly related to Parkin translocation.
Based on our observations of ROS dependency in MEFs, we reasoned that perhaps the lack of translocation in neurons might be due to the presence of antioxidants in the culture media. Indeed, we showed that depletion of such supplements revealed translocation induced by mitochondrial toxins, including CCCP, MPP + and rotenone. These results suggest that Parkin translocation mediated by depolarization of mitochondria or inhibition of mitochondrial complex I requires, at least in neurons (and in MEFs), the generation of ROS. However, care must be taken in interpreting the specifics of the ROS-mediated signal. Indeed, the source and localization of ROS is known to be critical for any particular biological outcome (43, 44) .
Interestingly, CCCP treatment induced qualitatively different translocation than that with H 2 O 2 in MEFs or MPP + or rotenone in neurons, which produced only partial Parkin translocation to mitochondria. Why this difference occurs is unknown. However, CCCP induces complete depolarization of mitochondria while MPP + is known to activate multiple death pathways both mitochondrial and independent of its role as a mitochondrial complex I inhibitor (45) . It should be noted that Parkin puncta observed in neurons are characteristically similar to those observed in other cell types (16, 31) in that these aggregates are also positive for ubiquitin. It is, however, difficult to distinguish whether enhanced ubiquitination in these aggregates is a result of Parkin's E3 ligasemediated ubiquitination of downstream targets (16) or a result of Parkin's auto-ubiquitination function (31) .
Finally, we have shown that the regulatory relationships between Parkin, Pink1 and DJ-1 in primary neurons are (46) .
In summary, we have clarified at least three critical issues in this report. First, we show that primary neurons can activate MQC-related Parkin translocation to mitochondria. Second, we demonstrate that ROS plays a central role in this process. Third, we provide evidence that DJ-1 regulates this process. Loss of DJ-1 leads to enhancement in Parkin translocation, and conversely, stress-mediated increase in mitochondrial DJ-1, an event previously shown to be critical for cell survival (30) , is impaired with Parkin and Pink1 deficiency. Taken together, we propose that in neurons, mitochondrial health and consequent sensitivity to environmental stress is regulated by at least two interrelated and parallel pathways that are in turn regulated via feedback from mitochondrial health. These pathways include: (a) the classic pathway of MQC involving Parkin translocation to damaged mitochondria, which are then eliminated via downstream clearance mechanisms and (b) Pink1/Parkin-regulated increase in mitochondrial DJ-1. In this latter case, we hypothesize that this may limit oxidative stress-induced damage at mitochondria to improve mitochondrial health.
MATERIALS AND METHODS
Transgenic mice
The generation and genotype of the Parkin, DJ-1 and Pink1-deficient mice have previously been described in detail, respectively (47) (48) (49) . All procedures involving animals were approved by the University of Ottawa Animal Care Committee and were maintained in strict accordance to the Guidelines for the Use and Treatment of Animals put forth by the Animal Care Council of Canada and endorsed by the Canadian Institute of Health Research.
Cell culture
MEFs were derived from E14.5-15.5 transgenic DJ-1 (C57BL/6), Pink1 (C57BL/6) and Parkin (mixed background) mice (Charles River Laboratories) of either sex and maintained in Dulbecco's modified Eagle's media (Sigma) supplemented with 10% fetal bovine serum (Sigma) and antibiotic/ antimycotic (Sigma). All MEFs were immortalized as previously described (25) . Fractionation experiments were performed on a near confluent (90 -95%) 100 mm plate and were treated with 100 mM H 2 O 2 for up to 6 h to induce oxidative stress. Cortical neurons were derived from E14.5 -15.5 WT CD1 mice or C57BL/6 WT/transgenic Pink1/transgenic DJ-1 mice (Charles River Laboratories) of either sex and maintained in Neurobasal media (Invitrogen) supplemented with B27 with antioxidants (Gibco), N2 (Gibco), 0.5 mM L-glutamine (Sigma) and penicillin/streptomycin (Gibco) as previously reported (22) . For DJ-1 studies of mitochondrial-100 mm plates at a density of 4 -5 × 10 6 cells/100 mm plate. For immunofluorescence of endogenous DJ-1, neurons were plated on PDL-coated coverslips in 24-well plates at a density of 100 000 cells per well. For all DJ-1 studies, on DIV5, media were completely changed to media identical to initial plating, with the exception of including B27 without antioxidants (Gibco). Neurons were treated with 30 mM H 2 O 2 for up to 6 h, 10 mM MPP + (Sigma) for up to 24 h or 10 mM CCCP (Sigma) for up to 2 h to induce oxidative stress. All treatments finished on DIV6.
Antibodies, plasmids and virus
The following antibodies were used: rabbit anti-DJ-1 (Abcam), mouse anti-Parkin (Santa Cruz), mouse anti-NDUFA9 (MitoSciences), mouse anti-mtHSP70 (Abcam), mouse anti-COX V (MitoSciences), mouse anti-COX I (MitoSciences), rabbit anti-TOM20 (Santa Cruz), rabbit anti-LC3 (Novus Biologicals), rabbit anti-calnexin (Abcam), mouse anti-actin (Sigma), rabbit anti-ubiquitin (Abcam), rabbit anti-Raf-1 (Santa Cruz) and antimouse and anti-rabbit horse radish peroxidase-conjugated secondary antibody (Bio-Rad). Construction of the FLAG-DJ-1 pcDNA3.1 has been described before (47) . The FLAG-C106A mutant was generated by site-directed mutagenesis of the FLAG-DJ-1. emGFP-Parkin AAV was generated and purified as described (50) .
Infection/transfection
For infection of mouse cortical neurons, cortical cultures were prepared as described above. A total of 5 × 10 5 neurons were plated into 24-well plates containing coverslips that were acid treated with 1 N nitric acid and 1 N HCl and pre-coated with 1× PDL and lamminin. Cultures were infected with GFPParkin AAV at the time of plating at an MOI of 5. Fresh growth media were added to the conditioned media at the Figure 11 . Schematic representation of DJ-1 and Pink/Parkin interplay during oxidative stress. The Pink1/Parkin MQC pathway is activated by increased ROS levels due to oxidative stress and/or mitochondrial damage in order to maintain mitochondrial health. Stress-induced DJ-1 requires Pink1/Parkin to help maintain mitochondrial health, possibly through inhibiting ROS directly or through other unknown MQC pathways in parallel to Pink1/Parkin. ratio of 1:1 every 3 days of culture. On DIV7, media from the wells were aspirated and replaced with fresh growth media similar to that used at the time of plating with the exception of B27. Treatments were performed on DIV8 using 10× working stocks of CCCP, rotenone (Sigma) or MPP + . For MEFs, 5 × 10 4 cells were seeded into 24-well plates containing PDL pre-coated coverslips 1 day before the day of transfection. GFP -Parkin -pEGFP construct was transfected into the cells using Lipofectamine (Invitrogen) following manufacturer's recommendations. For co-transfections, GFP -ParkinpEGFP was co-transfected with either the empty vector, WT FLAG-DJ-1 or FLAG-C106A at a ratio of 1:3 using Effectene Transfection Reagent (Qiagen) as per manufacturer's recommendations. Twenty-four hours after transfection, cells were treated with 10 mM CCCP or 100 mM hydrogen peroxide for indicated amounts of time. For antioxidant studies, cells were pre-treated for 3 h with either 100 mM TIRON (Sigma) or 2 mM N-acetyl cysteine (Sigma) prior to oxidative insult.
Immunofluorescence, quantification of Parkin translocation and mitochondrial fluorescence intensity
For endogenous DJ-1, following treatment, cells were fixed in 4% formalin in growth media at 378C for 15 min. The cells were permeabilized and blocked simultaneously using 0.1% Triton X-100 and 5% normal goat serum for 1 h at room temperature. Hybridizations using the respective primary antibodies were performed overnight at 48C. Cells were subsequently washed in 5% normal goat serum and stained with the corresponding secondary antibodies. Cells were subsequently washed in 1× PBS, stained with Hoechst, mounted and analyzed by confocal microscopy.
For Parkin translocation experiments, following drug treatments, the cells were fixed in 4% formalin in growth media at 378C for 15 min. The cells were permeabilized using 0.2% Triton X-100 for 5 min at room temperature, followed by blocking using 2.5% normal goat serum for 1 h at room temperature. Hybridizations using the respective primary antibodies were performed either at 378C for 30 min or at 48C overnight. Cells were subsequently washed in 1× PBS and stained with the corresponding secondary antibodies. Cells were finally stained with Hoechst, mounted and were analyzed by confocal microscopy. Quantifications of Parkin translocation were performed using an inverted fluorescence microscope. Cells displaying Parkin puncta were scored among the cells that were positive for GFP -Parkin staining.
For quantification of mitochondrial fluorescence intensity, all confocal photomicrographs were taken using identical conditions. Using NIH ImageJ software, an outline of the individual cell was drawn using the GFP staining as a cue. Mitochondrial staining intensity within this region of interest was measured, which is indicative of total mitochondrial staining intensity relative to the total area of the region of interest. At least 25 cells were counted per condition. Bar diagram is representative of two independent experiments.
Mitochondrial fractionation
Fractionation was performed identically for both MEFs and neurons. Briefly, cells were washed once with PBS and scraped in 1.2 ml of PBS into a 1.5 ml Eppendorf tube. From each sample, 300 ml of cell suspension was saved for whole-cell lysate. Harvested cells were centrifuged at 5000 rpm for 5 min at 48C in an Eppendorf Centrifuge 5417R. The cell pellet was resuspended in 250-500 ml of isolation buffer (0.25 M sucrose, 10 mM Tris, pH 7.5, 1 mM EDTA, freshly added protease inhibitors) and passed through a 27-gauge insulin syringe 35 times. Samples were then centrifuged at 610g for 10 min at 48C. The supernatant was then transferred to a new tube and centrifuged at 10 000g for 20 min at 48C. The supernatant (cytosolic fraction) was transferred to a new tube and the pellet (mitochondrial-enriched fraction) was resuspended in 25 -50 ml of isolation buffer. The whole-cell lysis pellet was resuspended in 50-100 ml of lysis buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.2% NP-40 and freshly added 1 mM DTT and protease inhibitors), vortexed for 10 s at maximum setting and incubated on ice for 30 min. Samples were stored at 2808C.
Immunoblotting
Protein quantification was carried out using the traditional Bradford (Bio-Rad) method. For mitochondrial-enriched blots, 10 mg of each sample was electrophoresed on 12% sodium dodecyl sulfate polyacrylamide gels and transferred to polyvinylidene fluoride membranes (Millipore). For relative wholecell, mitochondrial-enriched fractions and cytoplasmic fractions comparisons, sample amounts were calculated based on cell number. Membranes were probed with the respective primary antibodies followed by horseradish peroxidaseconjugated secondary antibodies and developed with the Immobilon Western Chemiluminescent HRP Substrate (Millipore).
Survival assay
For survival assay, primary cortical neurons infected with GFP -Parkin AAV were prepared as mentioned before. Following 48 h of MPP + treatment, cells were fixed and stained with Hoechst and the number of GFP-positive apoptotic nuclei counted under fluorescence microscope.
Statistical analysis
Statistical significance was determined using paired Student's t-test for related samples. Two-way ANOVA was used in select immunoblots to determine significance between WT and KO in control and treated conditions. All data are presented as mean + standard error of the mean (SEM). Significance at * P , 0.05, * * P , 0.01 and * * * P , 0.001; no significance is denoted by n.s.
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